ITUS Corporation (ITUS) Taps Tacere Therapeutics' Catelani as CFO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- Stocks hit by tech slide; yen flails at intervention zone
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- Oil steady as US demand concerns balance Middle East conflict risks
- Yen hits fresh 34-year lows against dollar ahead of BOJ meeting
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Crude Inventory Declined 6.4 Million Barrels Last Week
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
ITUS Hires Michael Catelani as Chief Financial Officer
October 24, 2016 9:00 AM EDTLOS ANGELES, CA -- (Marketwired) -- 10/24/16 -- ITUS Corporation ("ITUS") (NASDAQ: ITUS), today announced that Michael Catelani has joined the company as its new Chief Financial Officer, effective November 1, 2016. Mr. Catelani replaces Henry Herms, who will retire at the end of December after 21 years with the company.
Robert Berman, ITUS's President and CEO, stated, "We owe a debt of gratitude to Henry Herms for his many years of outstanding service to the company. We... More
